Recent Company News

• 02:04 AM ET Dec 08, 2025
  

  Oxford Nanopore Technologies appoints Francis Van Parys as CEO, effective 2-Mar-26 (125.0000p, 0)

• 01:10 PM ET Dec 03, 2025
  

  Transcript Intelligence: Oxford Nanopore Technologies at Piper Sandler Healthcare Conference (132.0000p, 0)

• 10:43 AM ET Dec 02, 2025
  

  Transcript Intelligence: Oxford Nanopore Technologies at Citi Global Healthcare Conference (130.0000p, -9)

• 04:01 AM ET Nov 07, 2025
  

  Oxford Nanopore Technologies plc postpones investor event; reaffirms guidance (133.6000p, -0.1)

• 07:02 AM ET Oct 09, 2025
  

  Bio-Techne and Oxford Nanopore Technologies expand agreement to accelerate development of genetics portfolio through 2032 ($60.56, 0.00)

• 02:56 AM ET Sep 02, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:42 AM ET Sep 02, 2025
  

  Oxford Nanopore Technologies reports H1 net income (£71.8M) vs FactSet (£72.7M) [2 est, (£75.9)-(69.5M)]; FY25 and medium-term guidance on track (185.3000p, 0)

• 02:14 AM ET Aug 27, 2025
  

  Oxford Nanopore Technologies initiated hold at Panmure Liberum (199.7000p, 0)

• 02:02 AM ET Aug 11, 2025
  

  Oxford Nanopore Technologies plc CEO Gordon Sanghera to step down by the end of 2025; (215.0000p, 0)

• 04:17 AM ET Jul 29, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (66 total)